QUOTE AND NEWS
Benzinga  Jul 14  Comment 
Chardan Capital’s Madhu Kumar believes Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) is faced with several challenges, including lack of clinical data and presence of “competitive barriers” for targeted indications. Kumar initiated...
Benzinga  Jul 11  Comment 
Although there are catalysts for Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) in 2H16, the inferior dosing schedule for coversin and stiff competition pose risks, Chardan Capital Markets’ Madhu Kumar said in a report. He initiated coverage of the...
Benzinga  Jul 7  Comment 
JMP Securities’ Liisa A. Bayko believes Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN)'s stock valuation is compelling at the current levels and reflect the HCV opportunity to a large extent. Bayko upgraded the rating on the company from Market...
Motley Fool  Jun 20  Comment 
Progress on short-duration hepatitis C therapies has failed to ignite investors' interest.
Motley Fool  Jun 2  Comment 
The potential for its clinical stage drugs to significantly shorten the duration of hepatitis C treatment could prove profit-friendly.
Benzinga  Jan 4  Comment 
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) today announced that Joel Barrish, Ph.D., has been named the Company's Chief Scientific Officer (CSO) and Executive Vice President, effective January 4, 2016. "It is with great excitement that we...





You may also be interested in articles related to Achillion Pharmaceuticals (ACHN):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki